Companies House · 12474195

CELIX PHARMA LTD

UK registered company, private limited company, incorporated 20 Feb 2020.

Active
32
Public contracts
0
Spend payments
Total spend

CELIX PHARMA LTD is a UK company registered at Companies House under number 12474195. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
12474195
Status
Active
Company type
Private Limited Company
Incorporated
20 Feb 2020
Country of origin
United Kingdom
Registered office
12 CONSTANCE STREET, LONDON, E16 2DQ, UNITED KINGDOM
Nature of business (SIC)
21200 - Manufacture of pharmaceutical preparations; 46460 - Wholesale of pharmaceutical goods
Accounts category
TOTAL EXEMPTION FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to CELIX PHARMA LTD.

ProcurementBuyerAwardedValue
NP Generic Medicines Transition Tender (October 2023)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP35925 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS National Transition Framework for Apremilast, Pazopanib and DapagliflozinNHS England
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)NHS England
NHS National Framework for Transition products commencing 1 May 2024NHS England
NHS National Framework for Transition products commencing 1 October 2024NHS England
Transitional Drugs 3Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
NHS National Framework Agreement for the supply of products for the management of Hereditary AngioedemaNHS England
NHS National Pharmaceuticals Transition 2022_1NHS England
NHS National Generic Pharmaceuticals Wave 14aNHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)NHS England25 Feb 2026£14.8m
NHS Generic Pharmaceuticals - Wave 15cNHS England13 Jan 2026£403.7m
NHS Generic Pharmaceuticals - Wave 15cNHS England13 Jan 2026£17.7m
NHS National Transition Framework for Apremilast, Pazopanib and DapagliflozinNHS England25 Nov 2025£25.9m
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
NHS National Framework for Transition products commencing 1 October 2024NHS England29 Sept 2024£16.2m
NHS National Framework for Transition products commencing 1 May 2024NHS ENGLAND15 Apr 2024£7.6m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
Hereditary AngioedemaNHS England19 Jun 2022£74.5m

Supplier identities

How this company appears as a supplier across the data.

FAQs about CELIX PHARMA LTD

Is CELIX PHARMA LTD an active company?

CELIX PHARMA LTD (company number 12474195) is recorded as "Active", incorporated on 20 Feb 2020.

What does CELIX PHARMA LTD do?

Its Companies House nature-of-business (SIC) is: 21200 - Manufacture of pharmaceutical preparations; 46460 - Wholesale of pharmaceutical goods.

Has CELIX PHARMA LTD won UK public-sector contracts?

Yes — 32 public-sector contract awards are linked to this company in our data.

Where is CELIX PHARMA LTD based?

Its registered office is 12 CONSTANCE STREET, LONDON, E16 2DQ, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable